Organon (OGN) Deferred Taxes (2020 - 2026)
Organon (OGN) posted Deferred Taxes of $16.0 million for Q2 2026, up 433.33% on a QoQ basis from $3.0 million in Q1 2026, and up 60.0% year-over-year from $10.0 million in Q2 2025.
Analysis
Organon (OGN) Deferred Taxes (2020 - 2026) Analysis & Trends
Organon has reported Deferred Taxes for 7 years, with the latest figure at $16.0 million in Q2 2026.
- On a quarterly basis, Deferred Taxes rose 60.0% year-over-year to $16.0 million in Q2 2026; TTM through Jun 2026 was $89.0 million, a 146.11% increase from a year earlier, with the FY2025 full-year figure at $63.0 million, up 139.37% from the prior year.
- Deferred Taxes was $16.0 million for Q2 2026 at Organon, up from $3.0 million in the prior quarter.
- The five-year high for Deferred Taxes was $40.0 million in Q3 2025, with the low at -$489.0 million in Q4 2023.
- Average Deferred Taxes over 5 years is -$33.4 million, with a median of $3.0 million recorded in 2023.
- The largest YoY upside for Deferred Taxes was 400.0% in 2024 against a maximum downside of 2550.0% in 2024.
- Over 5 years, Deferred Taxes stood at -$20.0 million in 2022, then plunged by 2345.0% to -$489.0 million in 2023, then surged by 102.04% to $10.0 million in 2024, then jumped by 200.0% to $30.0 million in 2025, then tumbled by 46.67% to $16.0 million in 2026.
- The last three Deferred Taxes figures came in at $16.0 million (Q2 2026), $3.0 million (Q1 2026), and $30.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | -479.00 Mn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | -195.00 Mn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | -544.00 Mn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | - |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | -1.32 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 115.62 Mn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 25.70 Mn |
| 10 | Organon | 3.58 Bn | 2.45 Bn | 847.00 Mn | 16.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 30.00 Mn |
| Sep 30, 2025 | 40.00 Mn |
| Jun 30, 2025 | 10.00 Mn |
| Mar 31, 2025 | -17.00 Mn |
| Dec 31, 2024 | 10.00 Mn |
| Sep 30, 2024 | -196.00 Mn |
| Jun 30, 2024 | 21.00 Mn |
| Mar 31, 2024 | 5.00 Mn |
| Dec 31, 2023 | -489.00 Mn |
| Sep 30, 2023 | 8.00 Mn |
| Jun 30, 2023 | -7.00 Mn |
| Mar 31, 2023 | 3.00 Mn |
| Dec 31, 2022 | -20.00 Mn |
| Sep 30, 2022 | -9.00 Mn |
| Jun 30, 2022 | -5.00 Mn |
| Mar 31, 2022 | -4.00 Mn |
| Dec 31, 2021 | -76.00 Mn |
| Sep 30, 2021 | -41.00 Mn |